Why one letter could help Moderna avoid TM rejection

Credit: Giovanni Cancemi / Adobe Stock
The ‘M’ in the company’s ‘COVID MVAX’ applied-for trademark could help it prevail against claims of genericism, though the outcome is still uncertain, say counsel
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: